Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

New treatments for lupus show promise, but more research is needed, especially for children.

COVID-19 vaccination may trigger lupus in some people.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Belimumab effectively controls SLE disease activity and reduces steroid use.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.